Biopharma | December 08, 2025
Halozyme wins German injunction blocking Merck’s Keytruda distribution
While Merck can appeal, Halozyme said it expects the order to hold
While Merck can appeal, Halozyme said it expects the order to hold
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
Subscribe To Our Newsletter & Stay Updated
